1. Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review
   Reshma Murali et al, 2023, Medical Oncology CrossRef
2. Harnessing type I interferon-mediated immunity to target malignant brain tumors
   Juhee Lim et al, 2023, Frontiers in Immunology CrossRef
3. The Therapeutic Values of IL-7/IL-7R and the Recombinant Derivatives in Glioma: A Narrative Review
   Marjan Hesari et al, 2023, Journal of Interferon & Cytokine Research CrossRef
4. Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells
   Dakota W. Goad et al, 2023, Journal of Virology CrossRef
5. Combining PD-1/PD-L1 blockade with type I interferon in cancer therapy
   Ali Razaghi et al, 2023, Frontiers in Immunology CrossRef
6. The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression
   Nalini Srinivas et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
7. Preclinical evaluation of IAP0971, a novel immunocytokine that binds specifically to PD1 and fuses IL15/IL15Rα complex
   Jihong Chen et al, 2023, Antibody Therapeutics CrossRef
8. The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7
   Wujun Chen et al, 2024, Cardiovascular Diabetology CrossRef
9. Effects of Interferon-α on Depressive-Like Behavior and Brain Neurochemistry in Rats Housed in Standard and Overcrowding Conditions
   N. A. Loginova et al, 2023, Journal of Evolutionary Biochemistry and Physiology CrossRef